Like so many others who live with chronic illness, I have to weigh the cost: benefit ratio of taking long-term medications for the management of my relapsing-remitting MS.
I’m very relieved that my neurologist wants me to switch to the lower dose of Aubagio, but I also realize that this lowered dose is considered to be less effective, too.
I also may not necessarily experience fewer side effects with my lower dose of Aubagio. Regardless, I do think that this option is worth pursuing.
